Elevated levels of Factor XI are associated with cardiovascular disease in women

被引:39
作者
Berliner, JI [1 ]
Rybicki, AC [1 ]
Kaplan, RC [1 ]
Monrad, ES [1 ]
Freeman, R [1 ]
Billett, HH [1 ]
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Div Hematol Cardiol Epidemiol & Endocrinol, Bronx, NY 10461 USA
关键词
Factor XI; coronary artery disease; thrombophilia;
D O I
10.1016/S0049-3848(02)00190-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary artery disease (CAD) continues to be the most frequent cause of death among women in the United States. Although elevated levels of clotting factors have been associated with CAD, few of these studies have been performed in women. Elevated levels of Factor XI have previously been associated with venous thrombosis, but little is known about its effect on arterial thrombosis. We selected women referred for cardiac catheterization who were found to have either normal coronaries or evidence of severe CAD and compared levels of homocysteine, anticardiolipin IgG/IgM antibodies, fibrinogen, platelet count, Factor VII, Factor VIII and Factor XI. Women with severe CAD had significantly higher levels of Factor XI than those without CAD (128% vs. 82%, p < 0.04). Statistical adjustment for age, diabetes, hypertension, total cholesterol (TC), current smoking, or BMI had no effect on the independent association between CAD status and Factor XI. Factor XI was higher in women with total cholesterol levels >6.18 mmol/l(>239 mg/dl) compared with normocholesteremic women and was also higher in the upper tertile of age, but even when adjusted for these, the association remained significant. This initial study suggests that Factor XI may be an important parameter in arterial as well as venous thrombosis. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 29 条
[1]   Anticardiolipin antibodies are not an independent risk factor for stroke - An incident case-referent study nested within the MONICA and Vasterbotten Cohort Project [J].
Ahmed, E ;
Stegmayr, B ;
Trifunovic, J ;
Weinehall, L ;
Hallmans, G ;
Lefvert, AK .
STROKE, 2000, 31 (06) :1289-1293
[2]  
BAUMANN RE, 1993, BLOOD, V82, P2117
[3]   Interaction of hemostatic genetics with hormone therapy - New insights to explain arterial thrombosis in postmenopausal women [J].
Braunstein, JB ;
Kershner, DW ;
Bray, P ;
Gerstenblith, G ;
Schulman, SP ;
Post, WS ;
Blumenthal, RS .
CHEST, 2002, 121 (03) :906-920
[4]   Gender-specific associations of the fibrinogen B beta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease [J].
Carter, AM ;
Catto, AJ ;
Bamford, JM ;
Grant, PJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :589-594
[5]  
CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380
[6]   PREVALENCE OF ANTICARDIOLIPIN ANTIBODIES IN CORONARY-ARTERY DISEASE [J].
DECATERINA, R ;
DASCANIO, A ;
MAZZONE, A ;
GAZZETTI, P ;
BERNINI, W ;
NERI, R ;
BOMBARDIERI, S .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (13) :922-923
[7]   Factor VIII and other hemostasis variables are related to incident diabetes in adults - The Atherosclerosis Risk in Communities (ARIC) study [J].
Duncan, BB ;
Schmidt, MI ;
Offenbacher, S ;
Wu, KK ;
Savage, PJ ;
Heiss, G .
DIABETES CARE, 1999, 22 (05) :767-772
[8]   Prospective study of hemostatic factors and incidence of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Wu, KK ;
Rosamond, WD ;
Sharrett, AR ;
Chambless, LE .
CIRCULATION, 1997, 96 (04) :1102-1108
[9]   Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis [J].
Giannitsis, E ;
Siemens, HJ ;
Mitusch, R ;
Tettenborn, I ;
Wiegand, U ;
Schmücker, G ;
Sheikhzadeh, A ;
Stierle, U .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1999, 68 (03) :269-274
[10]  
HAMSTEN A, 1986, LANCET, V1, P113